Patents Assigned to Aarhus University
  • EGFR blood monitoring
    Patent number: 9914975
    Abstract: Improved methods of assessing status of a solid-tumor cancer in a subject involving detection of tumor-associated mutations in the subject's blood.
    Type: Grant
    Filed: April 13, 2016
    Date of Patent: March 13, 2018
    Assignees: Roche Molecular Systems, Inc., Aarhus University
    Inventors: Peter Meldgaard, Boe Sorensen, Julie Tsai, Wei Wen, Lin Wu
  • Nod-factor perception
    Patent number: 7915485
    Abstract: The present invention provides a Nod-factor binding element, comprising one or more NFR polypeptides encoded by NFR genes, that are useful for providing non-nodulating plants with Nod-factor binding properties and triggering the endosymbiotic signalling pathway leading to nodulation. Furthermore the invention is useful for breeding for improved nodulation in nodulating legumes.
    Type: Grant
    Filed: July 2, 2004
    Date of Patent: March 29, 2011
    Assignee: Aarhus University
    Inventors: Jens Stougaard Jensen, Lene Heegaard Madsen, Elena Simona Radutoiu, Esben Bjorn Madsen, Niels Norgaard Sandel
  • METHODS AND PREPARATIONS FOR CURING CRITICALLY ILL PATIENTS
    Publication number: 20090181882
    Abstract: The present invention pertains to the use of a blood mannan-binding lectin (MBL) regulator for the manufacture of a life saving drug to treat or cure a critically ill patient. It further involves the use of measurements of MBL to predict mortality in critically ill ICU patients. One further aspect of present invention is to the use of monomers and oligomers of MBL in prophylactic and/or curative treatment of patients admitted to intensive care units (ICUs).
    Type: Application
    Filed: December 30, 2008
    Publication date: July 16, 2009
    Applicants: K.U. Leuven Research and Development, Aarhus Universitet, Aarhus University Hospital
    Inventors: Greta Van Den Berghe, Steffen Thiel, Troels Krarup Hansen
  • Nod-Factor Perception
    Publication number: 20080172763
    Abstract: The present invention provides a Nod-factor binding element, comprising one or more NFR polypeptides encoded by NFR genes, that are useful for providing non-nodulating plants with Nod-factor binding properties and triggering the endosymbiotic signalling pathway leading to nodulation. Furthermore the invention is useful for breeding for improved nodulation in nodulating legumes.
    Type: Application
    Filed: July 2, 2004
    Publication date: July 17, 2008
    Applicant: Aarhus University
    Inventors: Jens Stougaard Jensen, Lene Heegaard Madsen, Elena Simona Radutoiu, Esben Bjorn Madsen, Niels Norgaard Sandel
  • Methods and preparations for curing critically ill patients
    Publication number: 20060122102
    Abstract: The present invention pertains to the use of a blood mannan-binding lectin (MBL) regulator for the manufacture of a life saving drug to treat or cure a critically ill patient. It further involves the use of measurements of MBL to predict mortality in critically ill ICU patients. One further aspect of present invention is to the use of monomers and oligomers of MBL in prophylactic and/or curative treatment of patients admitted to intensive care units (ICUs).
    Type: Application
    Filed: September 23, 2003
    Publication date: June 8, 2006
    Applicants: K.U. Leuven Research and Development, Aarhus University Hospital
    Inventors: Greta Van Der Berghe, Steffen Thiel, Troels Hansen
  • Expression of heterologous genes from an IRES translational cassette in retroviral vectors
    Patent number: 7056730
    Abstract: The present invention relates to a retroviral vector which expresses a gene, e.g. for therapeutic use and/or of viral origin, under the translational control of an internal ribosomal entry site (IRES) resulting in the efficient translation of said gene.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: June 6, 2006
    Assignee: Aarhus University
    Inventors: Finn Skou Pedersen, Thomas Jesperson, Mogens Duch